Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Spinal cord & DRG stimulation · New Hampshire | Spinal cord & DRG stimulation · Pennsylvania | |
|---|---|---|
| Surgeons, 2024 | 2 | 32 |
| Medicare fee-for-service cases | 101 | 1,028 |
| Growth since 2019 (Medicare FFS) | +2.3%/yr | −1.4%/yr |
| Forecast cases (Medicare FFS) | 190 in 2030 | 980 in 2030 |
| Forecast growth | +11%/yr to 2030 | −0.7%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 0.4 | 0.7 |
| Medicare Advantage share | 39% | 58% |
| Out of hospital | 46% | 32% (+12 pts since 2019) |
| Cases per surgeon | 51 | 32 |
| Top 10 surgeons' share | 100% | 51% |
| Surgeons growing | 0 | 3 |
| New since the base year | 0 | 2 |
| Likely to stop billing it | 0 by 2026 | 14 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $17K | $25K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.